Turner Pope Investments will be holding an Investor Evening this Monday 13th May 2019. With spaces limited it is important you reserve your spot via the email address at bottom...
Deltex Medical Group plc (LON:DEMG) Chief Executive Officer Andy Mears caught up with DirectorsTalk for an exclusive interview to discuss their latest interim results. Q1: This morning, you published..
Deltex Medical Group Plc (LON:DEMG) CEO Andy Mears talks to DirectorsTalk about its interim results for the six months period ended 30 June 2018. Andy talks us through the highlights..
Deltex Medical Group plc (LON:DEMG), the global leader in oesophageal doppler monitoring has today announced its results for the six-month period ended 30 June 2018. Operational highlights * Andy Mears..
Deltex Medical Group plc (LON:DEMG) New Chief Executive Officer Andy Mears caught up with DirectorsTalk for an exclusive interview to discuss his new role as CEO, plans for the next..
Deltex Medical Group Plc (LON:DEMG) New CEO Andy Mears talks to DirectorsTalk about his new position. Andy talks about his background, how he thinks Deltex is positioned, his plans for..
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring, announced today that Ewan Phillips has resigned as Chief Executive and as a Director of the Company with..
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring, today gives notice that its Annual Report and Accounts for the year ended 31 December 2017 has been..
Deltex Medical Group plc (LON:DEMG) Chief Executive Officer Ewan Phillips caught up with DirectorsTalk for an exclusive interview to discuss their full year results, what’s been happening operationally, their strategy..
Deltex Medical Group (LON:DEMG) CEO Ewan Phillips talks to DirectorsTalk about its 2017 year end results. Ewan talks us through the highlights, explains whats been happening operationally this year, the..
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring, today announced its audited results for the year ended 31 December 2017. Statutory results · Operating loss reduced..
Deltex Medical Group plc (LON: DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), today announced the results of the largest randomised controlled trial to date of its proprietary fluid..
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), has today announced that its French distributor has been awarded a new tender to supply hospitals in..
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), has today announced the addition of a major new hospital in the USA. The hospital is a..
Deltex Medical Group Plc (LON:DEMG) CEO Ewan Phillips talks to DirectorsTalk about the launch of it’s TrueVue system in the US. Ewan explains it’s functionality, the situations it will be..
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), has today announced the launch this week of its revolutionary concept in advanced haemodynamic monitoring, the TrueVue™..
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), has today announced the addition of a significant new hospital account in the USA. The new account..
Deltex Medical Group plc (LON:DEMG), the global leader in oesophageal Doppler monitoring (“ODM”) today announced the release and first sales of its new High Definition Impedance Cardiography (HD-ICG) modality in..
Deltex Medical Group plc (LON:DEMG) Chief Executive Officer Ewan Phillips caught up with DirectorsTalk for an exclusive interview to discuss their interim results for the six months ended 30 June..
Deltex Medical Group Plc (LON:DEMG) CEO Ewan Phillips talks to DirectorsTalk about its positive interim results. Ewan talks us through the highlights, talks about the benefits of the new products..
